premia 2.5 continuous
pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); ; medroxyprogesterone acetate 2.6mg (includes 4% overage.); conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.); medroxyprogesterone acetate 2.6mg (includes 4% overage.) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide active: conjugated estrogens 0.625mg (15mg as a dessication with lactose, includes 3% overage.) medroxyprogesterone acetate 2.6mg (includes 4% overage.) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogol 20000 magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide
premia 5 continuous
pfizer new zealand limited - conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); ; medroxyprogesterone acetate 5mg (includes 4% overage); conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.); medroxyprogesterone acetate 5mg (includes 4% overage) - tablet - active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate iron oxide red lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide active: conjugated estrogens 0.625mg (15mg as a dessication with lactose. includes 3% overage.) medroxyprogesterone acetate 5mg (includes 4% overage) excipient: calcium sulfate carnauba wax glyceryl mono-oleate indigo carmine lactose monohydrate macrogols magnesium stearate methylcellulose microcrystalline cellulose opacode black s-8-27741 povidone shellac stearic acid sucrose titanium dioxide
premarin 1.25 mg prolonged-release tablets
pfizer healthcare ireland - conjugated estrogens - prolonged-release tablet - 1.25 milligram(s) - natural and semisynthetic estrogens, plain; conjugated estrogens
premarin 0.3 mg prolonged-release tablets
pfizer healthcare ireland - conjugated estrogens - prolonged-release tablet - 0.3 milligram(s) - natural and semisynthetic estrogens, plain; conjugated estrogens
premarin 0.625 mg prolonged-release tablets
pfizer healthcare ireland - conjugated estrogens - prolonged-release tablet - 0.625 milligram(s) - natural and semisynthetic estrogens, plain; conjugated estrogens
premarin intravenous powder for solution
pfizer canada ulc - conjugated estrogens - powder for solution - 25mg - conjugated estrogens 25mg - estrogens
c.e.s. tablet
bausch health, canada inc. - conjugated estrogens - tablet - 0.625mg - conjugated estrogens 0.625mg - estrogens
c.e.s. tablets
valeant canada lp / valeant canada s.e.c. - conjugated estrogens - tablet - 1.25mg - conjugated estrogens 1.25mg - estrogens
premarin tablets 0.9mg
wyeth canada - conjugated estrogens - tablet - 0.9mg - conjugated estrogens 0.9mg - estrogens
premarin tablet
pfizer canada ulc - conjugated estrogens - tablet - 0.3mg - conjugated estrogens 0.3mg - estrogens